ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 167 filers reported holding ALLAKOS INC in Q1 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $12,676,000 | -30.0% | 148,487 | -5.9% | 0.11% | -32.7% |
| Q1 2021 | $18,119,000 | -25.9% | 157,858 | -9.7% | 0.17% | -26.0% |
| Q4 2020 | $24,464,000 | +70.2% | 174,740 | -1.0% | 0.23% | +43.7% |
| Q3 2020 | $14,374,000 | +13.4% | 176,481 | +0.1% | 0.16% | +1.9% |
| Q2 2020 | $12,671,000 | +61.4% | 176,331 | -0.1% | 0.16% | +17.4% |
| Q1 2020 | $7,849,000 | -54.1% | 176,422 | -1.5% | 0.13% | -44.5% |
| Q4 2019 | $17,087,000 | – | 179,180 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
| Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
| TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
| Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
| Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
| Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
| NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
| COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
| BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
| Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |